Prevalence of SARS-COVID-19 serum IgG antibodies amongst staff on an acute surgical unit.
作者信息
Isherwood J, Winyard J, Karki B, Chung W Y, Layton G, Issa E, Garcea G, Dennison A R
机构信息
Department of Hepatobiliary and Pancreatic Surgery, Leicester General Hospital, Leicester, UK.
出版信息
Br J Surg. 2020 Nov;107(12):e576-e577. doi: 10.1002/bjs.11976. Epub 2020 Sep 9.
Abstract
摘要
相似文献
1
Prevalence of SARS-COVID-19 serum IgG antibodies amongst staff on an acute surgical unit.
Br J Surg. 2020 Nov;107(12):e576-e577. doi: 10.1002/bjs.11976. Epub 2020 Sep 9.
2
Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Virol Sin. 2020 Dec;35(6):744-751. doi: 10.1007/s12250-020-00268-5. Epub 2020 Jul 27.
3
Seroprevalence of SARS-CoV-2 IgG antibodies in the current COVID-19 pandemic amongst co-workers at a UK renal transplant centre.
Transpl Int. 2021 Feb;34(2):382-383. doi: 10.1111/tri.13791.
4
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Nat Commun. 2020 Nov 27;11(1):6044. doi: 10.1038/s41467-020-19943-y.
5
Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.
6
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
7
Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
J Med Virol. 2020 Sep;92(9):1684-1689. doi: 10.1002/jmv.25946. Epub 2020 May 5.
8
SARS-CoV-2 IgG seroprevalence among medical staff in a general hospital that treated patients with COVID-19 in Japan: retrospective evaluation of nosocomial infection control.
J Hosp Infect. 2021 Jan;107:103-104. doi: 10.1016/j.jhin.2020.10.001. Epub 2020 Oct 9.
9
Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Arch Pathol Lab Med. 2021 Jan 1;145(1):39-45. doi: 10.5858/arpa.2020-0310-SA.
10
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
Int J Hyg Environ Health. 2021 Mar;232:113671. doi: 10.1016/j.ijheh.2020.113671. Epub 2020 Nov 30.
引用本文的文献
1
Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis.
J Clin Nurs. 2022 Jun;31(11-12):1557-1569. doi: 10.1111/jocn.16009. Epub 2021 Sep 27.
本文引用的文献
1
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11.
2
Anesthesiologists' and Intensive Care Providers' Exposure to COVID-19 Infection in a New York City Academic Center: A Prospective Cohort Study Assessing Symptoms and COVID-19 Antibody Testing.
Anesth Analg. 2020 Sep;131(3):669-676. doi: 10.1213/ANE.0000000000005056.
3
What policy makers need to know about COVID-19 protective immunity.
Lancet. 2020 May 16;395(10236):1527-1529. doi: 10.1016/S0140-6736(20)30985-5. Epub 2020 Apr 27.
4
Global guidance for surgical care during the COVID-19 pandemic.
Br J Surg. 2020 Aug;107(9):1097-1103. doi: 10.1002/bjs.11646. Epub 2020 Apr 15.
Zotero 插件